Zagidullin, N.; Motloch, L.J.; Gareeva, D.; Hamitova, A.; Lakman, I.; Krioni, I.; Popov, D.; Zulkarneev, R.; Paar, V.; Kopp, K.;
et al. Combining Novel Biomarkers for Risk Stratification of Two-Year Cardiovascular Mortality in Patients with ST-Elevation Myocardial Infarction. J. Clin. Med. 2020, 9, 550.
https://doi.org/10.3390/jcm9020550
AMA Style
Zagidullin N, Motloch LJ, Gareeva D, Hamitova A, Lakman I, Krioni I, Popov D, Zulkarneev R, Paar V, Kopp K,
et al. Combining Novel Biomarkers for Risk Stratification of Two-Year Cardiovascular Mortality in Patients with ST-Elevation Myocardial Infarction. Journal of Clinical Medicine. 2020; 9(2):550.
https://doi.org/10.3390/jcm9020550
Chicago/Turabian Style
Zagidullin, Naufal, Lukas J. Motloch, Diana Gareeva, Aysilu Hamitova, Irina Lakman, Ilja Krioni, Denis Popov, Rustem Zulkarneev, Vera Paar, Kristen Kopp,
and et al. 2020. "Combining Novel Biomarkers for Risk Stratification of Two-Year Cardiovascular Mortality in Patients with ST-Elevation Myocardial Infarction" Journal of Clinical Medicine 9, no. 2: 550.
https://doi.org/10.3390/jcm9020550
APA Style
Zagidullin, N., Motloch, L. J., Gareeva, D., Hamitova, A., Lakman, I., Krioni, I., Popov, D., Zulkarneev, R., Paar, V., Kopp, K., Jirak, P., Ishmetov, V., Hoppe, U. C., Tulbaev, E., & Pavlov, V.
(2020). Combining Novel Biomarkers for Risk Stratification of Two-Year Cardiovascular Mortality in Patients with ST-Elevation Myocardial Infarction. Journal of Clinical Medicine, 9(2), 550.
https://doi.org/10.3390/jcm9020550